APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccine Delivery

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Vaccine Delivery Industry Research Report 2026

22 December 2025139 pages

Choose your research edition.

Industry ResearchOral Vaccine Delivery Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccine Delivery Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Oral Vaccine Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccine Delivery Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccine Delivery Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral Vaccine Delivery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Vaccine Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Vaccine Delivery is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Vaccine Delivery is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Vaccine Delivery include Lanzhou Institute, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech, Tiantan Biological and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Vaccine Delivery market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Vaccine Delivery Market by Company

Lanzhou Institute

Sanofi

Merck

Shanghai United Cell

GSK

Valneva

Vabiotech

Tiantan Biological

Serum Institute

PaxVax

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

Bio-Med

Bibcol

Oral Vaccine Delivery Segment by Type

Rotavirus Vaccine

Oral Polio Vaccine

Cholera Vaccine

Other

Oral Vaccine Delivery Segment by Application

Public

Private

Oral Vaccine Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccine Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccine Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccine Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Vaccine Delivery manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Vaccine Delivery by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Vaccine Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Vaccine Delivery Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Vaccine Delivery Sales (k units) of Manufacturers (2021-2026) Table 7. Global Oral Vaccine Delivery Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Vaccine Delivery Revenue of Manufacturers (2021-2026) Table 9. Global Oral Vaccine Delivery Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Vaccine Delivery Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Oral Vaccine Delivery Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Vaccine Delivery, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Vaccine Delivery, Product Type & Application Table 14. Global Oral Vaccine Delivery Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Vaccine Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Lanzhou Institute Company Information Table 19. Lanzhou Institute Business Overview Table 20. Lanzhou Institute Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Lanzhou Institute Oral Vaccine Delivery Product Portfolio Table 22. Lanzhou Institute Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sanofi Oral Vaccine Delivery Product Portfolio Table 27. Sanofi Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Merck Oral Vaccine Delivery Product Portfolio Table 32. Merck Recent Developments Table 33. Shanghai United Cell Company Information Table 34. Shanghai United Cell Business Overview Table 35. Shanghai United Cell Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Shanghai United Cell Oral Vaccine Delivery Product Portfolio Table 37. Shanghai United Cell Recent Developments Table 38. GSK Company Information Table 39. GSK Business Overview Table 40. GSK Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. GSK Oral Vaccine Delivery Product Portfolio Table 42. GSK Recent Developments Table 43. Valneva Company Information Table 44. Valneva Business Overview Table 45. Valneva Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Valneva Oral Vaccine Delivery Product Portfolio Table 47. Valneva Recent Developments Table 48. Vabiotech Company Information Table 49. Vabiotech Business Overview Table 50. Vabiotech Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Vabiotech Oral Vaccine Delivery Product Portfolio Table 52. Vabiotech Recent Developments Table 53. Tiantan Biological Company Information Table 54. Tiantan Biological Business Overview Table 55. Tiantan Biological Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Tiantan Biological Oral Vaccine Delivery Product Portfolio Table 57. Tiantan Biological Recent Developments Table 58. Serum Institute Company Information Table 59. Serum Institute Business Overview Table 60. Serum Institute Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Serum Institute Oral Vaccine Delivery Product Portfolio Table 62. Serum Institute Recent Developments Table 63. PaxVax Company Information Table 64. PaxVax Business Overview Table 65. PaxVax Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. PaxVax Oral Vaccine Delivery Product Portfolio Table 67. PaxVax Recent Developments Table 68. Panacea Biotec Ltd Company Information Table 69. Panacea Biotec Ltd Business Overview Table 70. Panacea Biotec Ltd Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio Table 72. Panacea Biotec Ltd Recent Developments Table 73. Halfkin Bio-Pharmaceuticals Company Information Table 74. Halfkin Bio-Pharmaceuticals Business Overview Table 75. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio Table 77. Halfkin Bio-Pharmaceuticals Recent Developments Table 78. EuBiologics Company Information Table 79. EuBiologics Business Overview Table 80. EuBiologics Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. EuBiologics Oral Vaccine Delivery Product Portfolio Table 82. EuBiologics Recent Developments Table 83. Bio-Med Company Information Table 84. Bio-Med Business Overview Table 85. Bio-Med Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bio-Med Oral Vaccine Delivery Product Portfolio Table 87. Bio-Med Recent Developments Table 88. Bibcol Company Information Table 89. Bibcol Business Overview Table 90. Bibcol Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bibcol Oral Vaccine Delivery Product Portfolio Table 92. Bibcol Recent Developments Table 93. Global Oral Vaccine Delivery Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Oral Vaccine Delivery Sales by Region (2021-2026) & (k units) Table 95. Global Oral Vaccine Delivery Sales Market Share by Region (2021-2026) Table 96. Global Oral Vaccine Delivery Sales by Region (2027-2032) & (k units) Table 97. Global Oral Vaccine Delivery Sales Market Share by Region (2027-2032) Table 98. Global Oral Vaccine Delivery Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Oral Vaccine Delivery Revenue Market Share by Region (2021-2026) Table 100. Global Oral Vaccine Delivery Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Oral Vaccine Delivery Revenue Market Share by Region (2027-2032) Table 102. North America Oral Vaccine Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 104. North America Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 105. North America Oral Vaccine Delivery Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Oral Vaccine Delivery Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Oral Vaccine Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 109. Europe Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 110. Europe Oral Vaccine Delivery Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Oral Vaccine Delivery Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Oral Vaccine Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Oral Vaccine Delivery Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Oral Vaccine Delivery Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Oral Vaccine Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 119. South America Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 120. South America Oral Vaccine Delivery Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Oral Vaccine Delivery Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Oral Vaccine Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Oral Vaccine Delivery Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Oral Vaccine Delivery Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 128. Global Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 129. Global Oral Vaccine Delivery Sales Market Share by Type (2021-2026) Table 130. Global Oral Vaccine Delivery Sales Market Share by Type (2027-2032) Table 131. Global Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2026) Table 134. Global Oral Vaccine Delivery Revenue Market Share by Type (2027-2032) Table 135. Global Oral Vaccine Delivery Price by Type (2021-2026) & (US$/unit) Table 136. Global Oral Vaccine Delivery Price by Type (2027-2032) & (US$/unit) Table 137. Global Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 138. Global Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 139. Global Oral Vaccine Delivery Sales Market Share by Application (2021-2026) Table 140. Global Oral Vaccine Delivery Sales Market Share by Application (2027-2032) Table 141. Global Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2026) Table 144. Global Oral Vaccine Delivery Revenue Market Share by Application (2027-2032) Table 145. Global Oral Vaccine Delivery Price by Application (2021-2026) & (US$/unit) Table 146. Global Oral Vaccine Delivery Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Oral Vaccine Delivery Distributors List Table 150. Oral Vaccine Delivery Customers List Table 151. Oral Vaccine Delivery Industry Trends Table 152. Oral Vaccine Delivery Industry Drivers Table 153. Oral Vaccine Delivery Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Vaccine Delivery Product Image Figure 5. Global Oral Vaccine Delivery Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Vaccine Delivery Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Vaccine Delivery Sales (2021-2032) & (k units) Figure 8. Global Oral Vaccine Delivery Average Price (US$/unit) & (2021-2032) Figure 9. Rotavirus Vaccine Product Image Figure 10. Oral Polio Vaccine Product Image Figure 11. Cholera Vaccine Product Image Figure 12. Other Product Image Figure 13. Public Product Image Figure 14. Private Product Image Figure 15. Global Oral Vaccine Delivery Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Oral Vaccine Delivery, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Oral Vaccine Delivery Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Oral Vaccine Delivery Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Oral Vaccine Delivery Sales by Region in 2025 Figure 21. Global Oral Vaccine Delivery Revenue by Region in 2025 Figure 22. North America Oral Vaccine Delivery Market Size by Country in 2025 Figure 23. North America Oral Vaccine Delivery Sales Market Share by Country (2021-2032) Figure 24. North America Oral Vaccine Delivery Revenue Market Share by Country (2021-2032) Figure 25. United States Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Oral Vaccine Delivery Market Size by Country in 2025 Figure 29. Europe Oral Vaccine Delivery Sales Market Share by Country (2021-2032) Figure 30. Europe Oral Vaccine Delivery Revenue Market Share by Country (2021-2032) Figure 31. Germany Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Oral Vaccine Delivery Market Size by Country in 2025 Figure 42. Asia Pacific Oral Vaccine Delivery Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Oral Vaccine Delivery Revenue Market Share by Country (2021-2032) Figure 44. China Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Oral Vaccine Delivery Market Size by Country in 2025 Figure 53. South America Oral Vaccine Delivery Sales Market Share by Country (2021-2032) Figure 54. South America Oral Vaccine Delivery Revenue Market Share by Country (2021-2032) Figure 55. Brazil Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Oral Vaccine Delivery Market Size by Country in 2025 Figure 59. Middle East and Africa Oral Vaccine Delivery Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Oral Vaccine Delivery Revenue Market Share by Country (2021-2032) Figure 61. Egypt Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Oral Vaccine Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Oral Vaccine Delivery Sales Market Share by Type (2021-2032) Figure 67. Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2032) Figure 68. Global Oral Vaccine Delivery Price (US$/unit) by Type (2021-2032) Figure 69. Global Oral Vaccine Delivery Sales Market Share by Application (2021-2032) Figure 70. Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2032) Figure 71. Global Oral Vaccine Delivery Price (US$/unit) by Application (2021-2032) Figure 72. Oral Vaccine Delivery Value Chain Figure 73. Oral Vaccine Delivery Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Oral Vaccine Delivery Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Oral Polio Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Public
  • Private
Companies covered
  • Lanzhou Institute
  • Sanofi
  • Merck
  • Shanghai United Cell
  • GSK
  • Valneva
  • Vabiotech
  • Tiantan Biological
  • Serum Institute
  • PaxVax
  • Panacea Biotec Ltd
  • Halfkin Bio-Pharmaceuticals
  • EuBiologics
  • Bio-Med
  • Bibcol

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Vaccine Delivery Market Size (2021-2032)
  4. 2.2.2 Global Oral Vaccine Delivery Sales (2021-2032)
  5. 2.2.3 Global Oral Vaccine Delivery Market Average Price (2021-2032)
  6. 2.3 Oral Vaccine Delivery by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rotavirus Vaccine
  9. 2.3.3 Oral Polio Vaccine
  10. 2.3.4 Cholera Vaccine
  11. 2.3.5 Other
  12. 2.4 Oral Vaccine Delivery by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Public
  15. 2.4.3 Private
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Vaccine Delivery Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Vaccine Delivery Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Vaccine Delivery Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Vaccine Delivery Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Vaccine Delivery Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Vaccine Delivery, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Vaccine Delivery, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Vaccine Delivery, Established Date
  9. 3.9 Global Oral Vaccine Delivery Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Lanzhou Institute
  2. 4.1.1 Lanzhou Institute Company Information
  3. 4.1.2 Lanzhou Institute Business Overview
  4. 4.1.3 Lanzhou Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Lanzhou Institute Oral Vaccine Delivery Product Portfolio
  6. 4.1.5 Lanzhou Institute Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Oral Vaccine Delivery Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Oral Vaccine Delivery Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Shanghai United Cell
  20. 4.4.1 Shanghai United Cell Company Information
  21. 4.4.2 Shanghai United Cell Business Overview
  22. 4.4.3 Shanghai United Cell Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai United Cell Oral Vaccine Delivery Product Portfolio
  24. 4.4.5 Shanghai United Cell Recent Developments
  25. 4.5 GSK
  26. 4.5.1 GSK Company Information
  27. 4.5.2 GSK Business Overview
  28. 4.5.3 GSK Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GSK Oral Vaccine Delivery Product Portfolio
  30. 4.5.5 GSK Recent Developments
  31. 4.6 Valneva
  32. 4.6.1 Valneva Company Information
  33. 4.6.2 Valneva Business Overview
  34. 4.6.3 Valneva Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Valneva Oral Vaccine Delivery Product Portfolio
  36. 4.6.5 Valneva Recent Developments
  37. 4.7 Vabiotech
  38. 4.7.1 Vabiotech Company Information
  39. 4.7.2 Vabiotech Business Overview
  40. 4.7.3 Vabiotech Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Vabiotech Oral Vaccine Delivery Product Portfolio
  42. 4.7.5 Vabiotech Recent Developments
  43. 4.8 Tiantan Biological
  44. 4.8.1 Tiantan Biological Company Information
  45. 4.8.2 Tiantan Biological Business Overview
  46. 4.8.3 Tiantan Biological Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Tiantan Biological Oral Vaccine Delivery Product Portfolio
  48. 4.8.5 Tiantan Biological Recent Developments
  49. 4.9 Serum Institute
  50. 4.9.1 Serum Institute Company Information
  51. 4.9.2 Serum Institute Business Overview
  52. 4.9.3 Serum Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Serum Institute Oral Vaccine Delivery Product Portfolio
  54. 4.9.5 Serum Institute Recent Developments
  55. 4.10 PaxVax
  56. 4.10.1 PaxVax Company Information
  57. 4.10.2 PaxVax Business Overview
  58. 4.10.3 PaxVax Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 PaxVax Oral Vaccine Delivery Product Portfolio
  60. 4.10.5 PaxVax Recent Developments
  61. 4.11 Panacea Biotec Ltd
  62. 4.11.1 Panacea Biotec Ltd Company Information
  63. 4.11.2 Panacea Biotec Ltd Business Overview
  64. 4.11.3 Panacea Biotec Ltd Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio
  66. 4.11.5 Panacea Biotec Ltd Recent Developments
  67. 4.12 Halfkin Bio-Pharmaceuticals
  68. 4.12.1 Halfkin Bio-Pharmaceuticals Company Information
  69. 4.12.2 Halfkin Bio-Pharmaceuticals Business Overview
  70. 4.12.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio
  72. 4.12.5 Halfkin Bio-Pharmaceuticals Recent Developments
  73. 4.13 EuBiologics
  74. 4.13.1 EuBiologics Company Information
  75. 4.13.2 EuBiologics Business Overview
  76. 4.13.3 EuBiologics Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 EuBiologics Oral Vaccine Delivery Product Portfolio
  78. 4.13.5 EuBiologics Recent Developments
  79. 4.14 Bio-Med
  80. 4.14.1 Bio-Med Company Information
  81. 4.14.2 Bio-Med Business Overview
  82. 4.14.3 Bio-Med Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bio-Med Oral Vaccine Delivery Product Portfolio
  84. 4.14.5 Bio-Med Recent Developments
  85. 4.15 Bibcol
  86. 4.15.1 Bibcol Company Information
  87. 4.15.2 Bibcol Business Overview
  88. 4.15.3 Bibcol Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bibcol Oral Vaccine Delivery Product Portfolio
  90. 4.15.5 Bibcol Recent Developments
5 Global Oral Vaccine Delivery Market Scenario by Region
  1. 5.1 Global Oral Vaccine Delivery Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Vaccine Delivery Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Vaccine Delivery Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Vaccine Delivery Sales by Region: 2027-2032
  5. 5.3 Global Oral Vaccine Delivery Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Vaccine Delivery Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Vaccine Delivery Revenue by Region: 2027-2032
  8. 5.4 North America Oral Vaccine Delivery Market Facts & Figures by Country
  9. 5.4.1 North America Oral Vaccine Delivery Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Vaccine Delivery Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Vaccine Delivery Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Vaccine Delivery Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Vaccine Delivery Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Vaccine Delivery Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Vaccine Delivery Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Vaccine Delivery Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Vaccine Delivery Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Vaccine Delivery Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Vaccine Delivery Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Vaccine Delivery Market Facts & Figures by Country
  41. 5.7.1 South America Oral Vaccine Delivery Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Vaccine Delivery Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Vaccine Delivery Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral Vaccine Delivery Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral Vaccine Delivery Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral Vaccine Delivery Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral Vaccine Delivery Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Vaccine Delivery Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Vaccine Delivery Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Oral Vaccine Delivery Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Vaccine Delivery Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Vaccine Delivery Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Vaccine Delivery Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Vaccine Delivery Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Vaccine Delivery Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Oral Vaccine Delivery Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Vaccine Delivery Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Vaccine Delivery Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Vaccine Delivery Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Vaccine Delivery Value Chain Analysis
  2. 8.1.1 Oral Vaccine Delivery Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Vaccine Delivery Production Mode & Process
  5. 8.2 Oral Vaccine Delivery Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Vaccine Delivery Distributors
  8. 8.2.3 Oral Vaccine Delivery Customers
9 Global Oral Vaccine Delivery Analyzing Market Dynamics
  1. 9.1 Oral Vaccine Delivery Industry Trends
  2. 9.2 Oral Vaccine Delivery Industry Drivers
  3. 9.3 Oral Vaccine Delivery Industry Opportunities and Challenges
  4. 9.4 Oral Vaccine Delivery Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst